TABLE 1.
Donor and recipient demographic characteristics.
| Variable | Levels | Values |
|---|---|---|
| Donor Age (years) | Median (IQR) | 23.0 (18.0–30.0) |
| Donor Sex | Female | 895 (30.7) |
| Male | 2022 (69.3) | |
| Donor Ethnicity | White, Non-Hispanic | 1714 (58.8) |
| Black, Non-Hispanic | 577 (19.7) | |
| Hispanic/Latino | 512 (17.6) | |
| Asian, Non-Hispanic | 67 (2.3) | |
| Other | 47 (1.6) | |
| Donor BMI (kg/m2) | Median (IQR) | 23.6 (21.1–26.2) |
| Cause of Death | Head Trauma | 1,535 (52.6) |
| Drug overdose | 437 (15.0) | |
| Other | 945 (32.4) | |
| Donor Type | DBD | 2,827 (96.9) |
| DCD | 90 (3.1) | |
| Recipient Age (years) | Median (IQR) | 42.0 (35.0–49.0) |
| Recipient Sex | Female | 1,123 (38.5) |
| Male | 1794 (61.5) | |
| Recipient Ethnicity | White, Non-Hispanic | 1,388 (47.6) |
| Black, Non-Hispanic | 830 (28.4) | |
| Hispanic/Latino | 520 (17.8) | |
| Asian, Non-Hispanic | 130 (4.5) | |
| Other | 49 (1.7) | |
| Recipient BMI (kg/m2) | Median (IQR) | 25.7 (23.1–28.6) |
| Recipient Diabetes Type | Type 1 | 2,232 (76.5) |
| Type 2 | 680 (23.3) | |
| Waiting Time (days) | Median (IQR) | 161.0 (50.0–421.0) |
| cPRA | ≤20 | 2,361 (80.9) |
| >20 | 553 (19.0) | |
| Previous Pancreas Transplant | No | 2,890 (99.1) |
| Yes | 27 (0.9) | |
| Recipient Dialysis Status | No | 659 (22.6) |
| Yes | 2,256 (77.4) | |
| HLA Mismatch | ≤2 | 102 (3.5) |
| 3 | 322 (11.0) | |
| 4 | 755 (25.9) | |
| 5 | 1,084 (37.2) | |
| 6 | 654 (22.4) | |
| CMV Match | P/N = Yes | 748 (25.6) |
| P/N = No | 2,137 (73.3) | |
| Duct Management | ED | 2,723 (93.4) |
| BD | 86 (3.0) | |
| Other | 108 (3.7) | |
| Steroid Maintenance | 0 | 805 (27.6) |
| 1 | 2007 (68.8) | |
| Tacrolimus and MMF Maintenance | No | 91 (3.1) |
| Yes | 2,795 (95.8) | |
| HbA1c at 1 Year (%) | Median (IQR) | 5.3 (5.0–5.7) |
| Treatment for Pancreas Rejection in 1st Year | No | 2,230 (76.5) |
| Yes | 199 (6.8) | |
| eGFR at 1 Year | Median (IQR) | 71.2 (57.8–87.3) |
| Treatment for Kidney Rejection in 1st Year | No | 2,251 (77.2) |
| Yes | 170 (5.8) |
BD, Bladder drainage; BMI, Body mass index; cPRA, Calculated panel reactive antibody; CMV, Cytomegalovirus; DBD, Donation after brain death; DCD, Donation after circulatory death; ED, Enteric drainage; eGFR, Glomerular filtration rate; HbA1c, Glycosylated hemoglobin; HLA, Human leukocyte antigen; HTK, Histidine-Tryptophan-Ketoglutarate; IQR, Interquartile range; MMF, Mycophenolate mofetil; P/N, Donor positive, recipient negative; SKP, Simultaneous kidney-pancreas transplantation; UW, University of Wisconsin solution.